MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches
At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read MoreTop Stories
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
Reimagining the MSL-KOL Relationship
MSL-KOL relationships: Medical Affairs teams and KOLs believe that approximately 40-50% of future interactions will...
The Changing Environment of Medical Affairs and Need for Increased Customer-Centricity
Medical Affairs will soon emerge as a frontline strategic division and grow in stature as...
Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences
The growth and adoption of the internet and mobile technology have provided publishers and authors...
What do Healthcare Professionals Want from Medical Affairs Post COVID-19?
Here's an interesting read for medical affairs teams on how to cater to the digital...
A 4-Step Plan to Drive HCP Engagement
HCPs are a time-constrained and hard-to-engage audience. Learn how pharma can digitally engage HCPs better...
MedTech Summit 2021: Understanding Post Market Clinical Follow Up (PCMF)
An ideal PMCF plan, with reference to MDCG 2020-7, presents the general and specific methods...